These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 26308720
41. Antisense oligonucleotide of tissue inhibitor of metalloproteinase-1 induces the plasminogen activator activity in periodontal ligament cells. Shibata Y, Takiguchi H, Abiko Y. J Periodontol; 1999 Oct; 70(10):1158-65. PubMed ID: 10534069 [Abstract] [Full Text] [Related]
42. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Bode W, Maskos K. Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053 [Abstract] [Full Text] [Related]
43. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [Abstract] [Full Text] [Related]
44. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Hilska M, Roberts PJ, Collan YU, Laine VJ, Kössi J, Hirsimäki P, Rahkonen O, Laato M. Int J Cancer; 2007 Aug 15; 121(4):714-23. PubMed ID: 17455256 [Abstract] [Full Text] [Related]
45. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme. Lee MH, Dodds P, Verma V, Maskos K, Knäuper V, Murphy G. Biochem J; 2003 Apr 15; 371(Pt 2):369-76. PubMed ID: 12556225 [Abstract] [Full Text] [Related]
46. Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase. Porter JF, Shen S, Denhardt DT. Br J Cancer; 2004 Jan 26; 90(2):463-70. PubMed ID: 14735194 [Abstract] [Full Text] [Related]
51. Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001. Kis-Toth K, Bacskai I, Gogolak P, Mazlo A, Szatmari I, Rajnavolgyi E. Immunobiology; 2013 Nov 26; 218(11):1361-9. PubMed ID: 23870824 [Abstract] [Full Text] [Related]
52. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct 26; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
54. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H. Exp Eye Res; 2002 May 26; 74(5):577-84. PubMed ID: 12076079 [Abstract] [Full Text] [Related]
55. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line. Lombard MA, Wallace TL, Kubicek MF, Petzold GL, Mitchell MA, Hendges SK, Wilks JW. Cancer Res; 1998 Sep 01; 58(17):4001-7. PubMed ID: 9731514 [Abstract] [Full Text] [Related]
56. Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2. Maskos K, Lang R, Tschesche H, Bode W. J Mol Biol; 2007 Mar 02; 366(4):1222-31. PubMed ID: 17196980 [Abstract] [Full Text] [Related]
57. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX. Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283 [Abstract] [Full Text] [Related]